Competition record
Stryker
Deep profile · 0 linked library matters
Stryker pairs hip and knee implants with the Mako robotic arm and also sells beds and stretchers to the same hospitals. A Mako installation pulls Triathlon and other Stryker joints, which is the contest with Zimmer Biomet's ROSA.
Overview
Stryker is based in Kalamazoo. Its orthopedic business sells hips, the Triathlon knee, trauma plates, and spine products, and Mako is the robotic arm that helps surgeons prepare the bone for those specific implants.
Zimmer Biomet, Johnson & Johnson's DePuy Synthes, and Smith & Nephew bid the same joint-replacement contracts. The robot is capital equipment approved by the hospital's surgery leadership, and the implants then flow as physician-preference items under a GPO price.
MedSurg products, including beds and stretchers, are a separate capital cycle sold to facilities managers rather than to orthopedic surgeons. A hospital can be a Stryker joint customer and a different vendor's bed customer, but the Mako-plus-implant link is tighter than that.
Competition footprint
Each Mako placement is a multi-year implant commitment because the saw and the implant are designed together.
Trauma and joint trays in the sterile core are brand-specific, so instrument sets occupy storage and staff time.
Bed and stretcher replacements follow facility budgets that do not move with the orthopedic contract.
Consumer & business angle
Surgeons trained on Mako lose that workflow if the hospital later standardizes on another robot.
Patients rarely see the brand, but the implant on the shelf is the one the robot was purchased to accept.
What to watch
- Mako placements against Zimmer Biomet ROSA and any DePuy robotic system in the same hospitals.
- Joint-implant price caps in bundled Medicare episodes, which can push hospitals to limit vendors.
Markets
orthopedic implants · surgical robotics · hospital beds
Also known as: mako, triathlon
Conduct themes
Linked cases in the library
No linked matters in the current library yet. The narrative above is still a market-power primer — check primary sources for live disputes.